AstraZeneca PLC Reports AGM Results
Ticker: AZN · Form: 6-K · Filed: 2026-04-09T13:01:44-04:00
Sentiment: neutral
Topics: AGM, corporate-governance, filing-update
TL;DR
AstraZeneca's AGM results are in, shareholders voted on key resolutions.
AI Summary
AstraZeneca PLC filed a Form 6-K on April 9, 2026, reporting the results of its Annual General Meeting (AGM). The filing details the outcomes of resolutions voted on by shareholders during the meeting.
Why It Matters
This filing provides shareholders with the official results of voting on key company matters at the Annual General Meeting, reflecting shareholder sentiment on corporate governance and strategic decisions.
Risk Assessment
Risk Level: low — This is a routine filing reporting the results of an Annual General Meeting, which is standard corporate practice and does not indicate new risks.
Key Players & Entities
- ASTRAZENECA PLC (company) — Filer
- 0000901832 (company) — CIK
- 0001654954-26-003374 (filing_id) — SEC Accession Number
- 2026-04-09 (date) — Filing Date and Period of Report
FAQ
What type of report is this SEC filing?
This is a Form 6-K, which is a Report of foreign issuer.
When was this filing accepted by the SEC?
The filing was accepted on April 9, 2026.
What is the CIK number for AstraZeneca PLC?
The CIK number for AstraZeneca PLC is 0000901832.
What is the primary document included in this filing?
The primary document is a report on the 'RESULT OF AGM' (Annual General Meeting).
Where is AstraZeneca PLC's mailing address listed?
AstraZeneca PLC's mailing address is listed as 1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, United Kingdom, CB2 0AA.
From the Filing
EDGAR Filing Documents for 0001654954-26-003374 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001654954-26-003374 Filing Date 2026-04-09 Accepted 2026-04-09 13:01:44 Documents 1 Period of Report 2026-04-09 Document Format Files Seq Description Document Type Size 1 RESULT OF AGM a8862z.htm 6-K 134127 Complete submission text file 0001654954-26-003374.txt 135423 Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE United Kingdom CB2 0AA Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE United Kingdom CB2 0AA 011 44 20 7304 5000 ASTRAZENECA PLC (Filer) CIK : 0000901832 (see all company filings) EIN. : 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231 Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 26850724 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)